ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
16,872.40
-0.77%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.22
-0.39%
Bitcoin
63,862.35
-3.84%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Biopharma Credit Plc (BPCR) Quote

Biopharma Credit Plc

Biopharma Credit Plc (BPCR)

LSE
0.878
0.002
(0.23%)
Closed April 24 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.878
Bid
0.876
Ask
0.88
Volume
5,349,757
0.876 Day's Range 0.88
0.81 52 Week Range 0.968
Market Cap
1.146B
Previous Close
0.876
Open
0.878
Last Trade
1017271
@
0.878
(O)
Last Trade Time
Financial Volume
$ 4,694,947
VWAP
0.8776
Average Volume (3m)
1,629,669
Shares Outstanding
1,302,679,192
Dividend Yield
7.97%
PE Ratio
10.56
Earnings Per Share (EPS)
0.08
Revenue
135.74M
Net Profit
108.45M

About Biopharma Credit Plc

Sector
Finance Services
Industry
Finance Services
Headquarters
London, Ontario, Can
Founded
1970
Biopharma Credit Plc is listed in the Finance Services sector of the London Stock Exchange with ticker BPCR. The last closing price for Biopharma Credit was $0.88. Over the last year, Biopharma Credit shares have traded in a share price range of $ 0.81 to $ 0.968.

Biopharma Credit currently has 1,302,679,192 shares outstanding. The market capitalization of Biopharma Credit is $1.15 billion. Biopharma Credit has a price to earnings ratio (PE ratio) of 10.56.

BPCR Latest News

More News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 24 April 2024   BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES   BioPharma Credit PLC announces that today it has purchased the following number of its...

6 hours ago
RNS Regulatory News

BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals

BioPharma Credit PLC on Wednesday announced it entered into a secured loan agreement with Tarsus Pharmaceuticals Inc. ...

14 hours ago
Alliance News

BioPharma Credit PLC NEW INVESTMENT OF UP TO US$100 MILLION

BioPharma Credit PLC 24 April 2024   24 April 2024    BIOPHARMA CREDIT PLC (THE "COMPANY")  NEW INVESTMENT OF UP TO US$100 MILLION    BioPharma Credit PLC (LSE: BPCR), the specialist life...

17 hours ago
RNS Regulatory News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 23 April 2024   BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES   BioPharma Credit PLC announces that today it has purchased the following number of its...

April 23 2024
RNS Regulatory News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 22 April 2024   BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES   BioPharma Credit PLC announces that today it has purchased the following number of its...

April 22 2024
RNS Regulatory News

BioPharma Credit PLC Net Asset Value(s) and Monthly Factsheet

BioPharma Credit PLC 22 April 2024   BIOPHARMA CREDIT PLC (the 'Company')   As at the 31 March 2024 the unaudited net asset value per Ordinary Share, including current period revenue, was...

April 22 2024
RNS Regulatory News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 19 April 2024   BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES   BioPharma Credit PLC announces that today it has purchased the following number of its...

April 19 2024
RNS Regulatory News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 18 April 2024   BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES   BioPharma Credit PLC announces that today it has purchased the following number of its...

April 18 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0020.2283105022830.8760.880.87420224660.876DE
4-0.028-3.090507726270.9060.910.8723314580.87860707DE
12-0.06-6.396588486140.9380.9380.8716296690.8920705DE
260.0384.523809523810.840.9420.8117407150.88881481DE
52-0.09-9.297520661160.9680.9680.8116098710.88775562DE
156-0.1-10.22494887530.9781.050.8117376270.94294794DE
260-0.182-17.16981132081.061.070.8114740520.95864496DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIREreAlpha Tech Corporation
$ 1.66
(43.10%)
5.9M
CDTXCidara Therapeutics Inc
$ 17.44
(41.90%)
244.11k
ILAGIntelligent Living Application Group Inc
$ 0.7011
(29.83%)
1.88M
THMOThermoGenesis Holdings Inc
$ 0.80
(23.08%)
1.47k
NUWENewellis Inc
$ 0.307
(21.78%)
1.85M
FBLGraniteShares ETF Trust GraniteShares
$ 18.44
(-31.12%)
1.58M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3073
(-27.75%)
8.08M
METAMeta Platforms Inc
$ 416.206
(-15.66%)
11.89M
BRTXBioRestorative Therapies Inc
$ 1.13
(-11.02%)
8.96k
AKLIAkili Inc
$ 0.221
(-10.89%)
5k
METAMeta Platforms Inc
$ 416.25
(-15.65%)
11.89M
SQQQProShares UltraPro Short QQQ
$ 12.19
(3.22%)
11.67M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3073
(-27.75%)
8.08M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0496
(-0.60%)
6.31M
AIREreAlpha Tech Corporation
$ 1.67
(43.97%)
5.9M

Discussion

View Full Feed
VeronicaFox VeronicaFox 5 minutes ago
No hedge fund, no air shares. That’s just another conspiracy theory.


https://investorshub.advfn.com/uimage/uploads/2024/4/24/jlgydIMG_2184.jpeg
KEGS
tothe tothe 5 minutes ago
HoldEm; I love the pink BB pinch. For a chart reader it is beyond elementary, it is a whisper into the future. Good work!
ILST
titan11 titan11 5 minutes ago
Roflmao
scotty3371 scotty3371 6 minutes ago
Tomorrow .44, market will get pounded.

My next bid is .41, which is next week.



NWBO
peanutz peanutz 6 minutes ago
This will tell a lot . I hope it is very good as do we all . About time to put up cause they are quiet enough already lol. :-)
SONX
biowin biowin 7 minutes ago
Then why do you care about "Bioamber" so much??? You are the biggest security guard on this company, it must be your first job after law school
gawti88 gawti88 7 minutes ago
lol dont worry hustle, this is a great legit company. This will run hard
CEOS
tdbowieknife tdbowieknife 7 minutes ago
I'm doing research on the fraud committed here. So, I occasionally check the websites. One worked, while the other didn't. It takes half a second to do it.

..

.
Hummingbird2 Hummingbird2 7 minutes ago
$FNGR $GTII

https://twitter.com/kshaughnessy2/status/1783192382894125490

💥
FNGR GTII
synaphai synaphai 7 minutes ago
Maybe it is an issue with the auditor. If it's still M&K CPAS, they have 3 awful reviews on Google but those are from 7-8 years ago and they did work on the 10K last year that got filed by the extension deadline. Obviously there has been a lot of mortgage juggling going on as 3 big mortgage payments
SNRG
NanoEE NanoEE 7 minutes ago
IN!

Still looking for the sneaky battery company that’s gonna pull up and past the stagnant performers.
QS
10thMountain 10thMountain 7 minutes ago
Um….there was no ‘runaway gap’. That only happens if big news hits. No big news has hit, so the mm’s took advantage….(and traders that know how to read charts) and closed the GAP. I know it sucks to be wrong, but maybe consider taking an anger management class or something….oh…and a chart class lol
TDRK
Itchy palm Itchy palm 8 minutes ago
He said I never committed to supporting the constitution of the United States 🇺🇸
DJT
slops slops 8 minutes ago
Most P R's have been released Thursday
VDRM
Westcoastplaya Westcoastplaya 8 minutes ago
Good things to come from this partnership with rapidly expanding 1ovmany imo.

Taner Kapucu and Mike Horwath are Founders and Co-CEOs of 1ovmany. Taner said, "Our partnership with Digital Clarity marks a significant milestone in our journey. Having the ability to partner with an indus
DBMM
crazy horse 0 crazy horse 0 9 minutes ago
LOL right on

Lock 'em up!!!
CBIA
Margin Buu Margin Buu 9 minutes ago
“I guess you could also program the computer to violate a regulation, but we haven’t gotten there yet”. - Bernie Madoff

We’ve definitely gotten there.
NWBO
JOHNNIEBG JOHNNIEBG 9 minutes ago
It sure is, you must not get much to eat!!!!!
DJT
Lurker3 Lurker3 9 minutes ago
I feel you. I was offered a long time ago with a pp to get in at 11 cents.

I told a friend of mine the same as you when he showed me the email with that guy saying that he would vote yes for the spac

Get out before you can coz the spac business model is in default. I do
LWLG
rosemountbomber rosemountbomber 9 minutes ago
Thanks for posting. The Fenofibrates would not be the only ones I would petition the FDA about. I know people will say they have no control over it, but if I sold a bottle of fish oil and told people that it will reduce CVD the FDA or FTC would come after me (if they had the resources, etc,) but i
AMRN
Involuntary-Recluse Involuntary-Recluse 9 minutes ago
Ben Berry you can be the king of the OTC again.

Lets goooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo :-)
Bring CLHI to the promised land............


:-)
CLHI
Ibhenry Ibhenry 10 minutes ago
Have you searched $RDGL on X lately? 😭
RDGL
Horsin around Horsin around 10 minutes ago
Why wouldn't these be done or near complete by 4/1? What would cause a delay as they seem pretty routine?

Unless it's due to a potential sale of assets or even acquisition that came about close to 4/1. Maybe wishful thinking on my part.
SNRG
newlevel87 newlevel87 10 minutes ago
We moving on up
BNGI
Hummingbird2 Hummingbird2 10 minutes ago
https://twitter.com/kshaughnessy2/status/1783192382894125490

$GTII
GTII

Your Recent History

LSE
BPCR
Biopharma Credit
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved